235
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Uptake, Safety and Attitudes Towards COVID-19 Vaccination: A Cross-Sectional Study on First and Second Doses Among the General Public

ORCID Icon, ORCID Icon, , , , , ORCID Icon, , , , & show all
Pages 1633-1643 | Received 08 May 2023, Accepted 26 Jul 2023, Published online: 18 Aug 2023

References

  • World Health Organization. WHO coronavirus (COVID-19) dashboard: overview; 2023. Available from: https://covid19.who.int/?adgroupsurvey=%7Badgroupsurvey%7D&gclid=Cj0KCQiAw8OeBhCeARIsAGxWtUxR9wuVfKmK8awaDLSRrSm65bKiEJOcvWX34XpP2LX4eD_sR9ZfUqAaArNPEALw_wcB. Accessed March 7, 2023.
  • World Health Organization. Saudi Arabia Situation on COVID-19; 2022. Available from: https://covid19.who.int/region/emro/country/sa. Accessed August 5, 2022.
  • Assiri A, Al-Tawfiq JA, Alkhalifa M, et al. Launching COVID-19 vaccination in Saudi Arabia: lessons learned, and the way forward. Travel Med Infect Dis. 2021;43:102119. doi:10.1016/j.tmaid.2021.102119
  • COVID-19 vaccine tracker. Saudi Arabia; 2022. Available from https://covid19.trackvaccines.org/country/saudi-arabia/. Accessed August 19, 2022.
  • Wang C, Wang Z, Wang G, Lau JY-N, Zhang K, Li W. COVID-19 in early 2021: current status and looking forward. Signal Transduct Target Ther. 2021;6(1):114. doi:10.1038/s41392-021-00527-1
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
  • Priyanka COP, Singh I, Singh I. Making sound public health decisions for the roll-out of COVID-19 vaccines. J Travel Med. 2021;28(4). doi:10.1093/jtm/taab031
  • Salam AA, Al-Khraif RM, Elsegaey I. COVID-19 in Saudi Arabia: an overview. Front Public Health. 2022;9:2258. doi:10.3389/fpubh.2021.736942
  • Kyriakidis NC, López-Cortés A, González EV, Grimaldos AB, Prado EO. SARS-CoV-2 vaccines strategies: a comprehensive review of Phase 3 candidates. Npj Vaccines. 2021;6(1):28. doi:10.1038/s41541-021-00292-w
  • Choudhary OP. Vaccine efficacy against COVID-19: a foresight on the host-associated factors. J Formos Med Assoc. 2021;120(6):1405–1407. doi:10.1016/j.jfma.2020.11.021
  • El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLoS One. 2021;16(4):e0250555. doi:10.1371/journal.pone.0250555
  • Neergaard L, Fingerhut H. AP-NORC poll: half of Americans would get a COVID-19 vaccine. AP News; 2020.
  • Alshahrani SM, Dehom S, Almutairi D, et al. Acceptability of COVID-19 vaccination in Saudi Arabia: a cross-sectional study using a web-based survey. Hum Vaccin Immunother. 2021;17(10):3338–3347. doi:10.1080/21645515.2021.1936869
  • Mahase E. Covid-19: pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows. Br Med J. 2020;371:m4826. doi:10.1136/bmj.m4826
  • Mahase E. Covid-19: reports from Israel suggest one dose of Pfizer vaccine could be less effective than expected. Br Med J. 2021;372:n217. doi:10.1136/bmj.n217
  • Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant. N Engl J Med. 2021;385(7):585–594. doi:10.1056/NEJMoa2108891
  • Sheikh A, McMenamin J, Taylor B, Robertson C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397(10293):2461–2462. doi:10.1016/S0140-6736(21)01358-1
  • Tartof SY, Slezak JM, Fischer H, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021;398(10309):1407–1416. doi:10.1016/S0140-6736(21)02183-8
  • Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657–1663. doi:10.2147/JMDH.S276771
  • Alhasan K, Aljamaan F, Temsah M-H, et al. COVID-19 delta variant: perceptions, worries, and vaccine-booster acceptability among healthcare workers. Healthcare. 2021;9(11):1566. doi:10.3390/healthcare9111566
  • Almaghaslah D, Alsayari A, Kandasamy G, Vasudevan R. COVID-19 vaccine hesitancy among young adults in Saudi Arabia: a cross-sectional web-based study. Vaccines. 2021;9(4):330. doi:10.3390/vaccines9040330
  • Yahia AIO, Alshahrani AM, Alsulmi WGH, et al. Determinants of COVID-19 vaccine acceptance and hesitancy: a cross-sectional study in Saudi Arabia. Hum Vaccin Immunother. 2021;17(11):4015–4020. doi:10.1080/21645515.2021.1950506
  • Seid MA, Hussen MS. Knowledge and attitude towards antimicrobial resistance among final year undergraduate paramedical students at University of Gondar, Ethiopia. BMC Infect Dis. 2018;18:1–8. doi:10.1186/s12879-018-3199-1
  • Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149. doi:10.3389/fpubh.2018.00149
  • Raosoft, Inc. Raosoft Sample Size Calculator. Seattle; 2004. Available from: http://www.raosoft.com/samplesize.html. Accessed December 2, 2021.
  • Eysenbach G. Improving the quality of web Surveys: the Checklist For Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. doi:10.2196/jmir.6.3.e34
  • Al-Mansour K, Alyahya S, AbuGazalah F, Alabdulkareem K. Factors affecting COVID-19 vaccination among the general population in Saudi Arabia. MDPI. 2021;2021:1218.
  • Alzarea AI, Khan YH, Alatawi AD, et al. Surveillance of post-vaccination side effects of COVID-19 vaccines among Saudi population: a real-world estimation of safety profile. Vaccines. 2022;10(6):924. doi:10.3390/vaccines10060924
  • Andrzejczak-Grzadko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25(12):4418–4421. doi:10.26355/eurrev_202106_26153
  • El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389–1401. doi:10.2147/IJGM.S310497
  • Lane S, Shakir S. Assessing case fatality on cases of thrombosis with concurrent thrombocytopenia following COVID-19 vaccine AstraZeneca (Vaxzevria) in the United Kingdom: a review of spontaneously reported data. Drug Saf. 2022;45(9):1003–1008. doi:10.1007/s40264-022-01217-9
  • Medeiros KS, Costa APF, Sarmento ACA, Freitas CL, Gonçalves AK. Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials. BMJ open. 2022;12(2):e050278. doi:10.1136/bmjopen-2021-050278
  • Al-Qazaz HK, Al-Obaidy LM, Attash HM. COVID-19 vaccination, do women suffer from more side effects than men? A retrospective cross-sectional study. Pharm Pract. 2022;20(2):1–6. doi:10.18549/PharmPract.2022.2.2678
  • Choudhary OP, Mohammed TA, Singh I, Singh I. Intranasal COVID-19 vaccines: is it a boon or bane? Int J Surg. 2021;94:106119. doi:10.1016/j.ijsu.2021.106119
  • Fadhel FH. Vaccine hesitancy and acceptance: an examination of predictive factors in COVID-19 vaccination in Saudi Arabia. Health Promot Int. 2021. doi:10.1093/heapro/daab209
  • Al-Hanawi MK, Angawi K, Alshareef N, et al. Knowledge, attitude and practice toward COVID-19 among the public in the Kingdom of Saudi Arabia: a cross-sectional study. Front Public Health. 2020;8:217. doi:10.3389/fpubh.2020.00217
  • Mahmoud MA, Ibrahim AAM, Alolayan SO, Bhagavathula AS. A study of public knowledge and pharmacists perceptions of their roles in prevention of COVID-19. Lat Am J Pharm. 2021;40(4):871–878.
  • Wajid S, Samreen S, Sales I, Bawazeer G, Mahmoud MA, Aljohani MA. What has changed in the behaviors of the public after the COVID-19 pandemic? A cross-sectional study from the Saudi community perspective. Front Public Health. 2022;10. doi:10.3389/fpubh.2022.723229